UY23355A1 - Formulacion para verter destinada a la aplicacion de antihelminticos - Google Patents

Formulacion para verter destinada a la aplicacion de antihelminticos

Info

Publication number
UY23355A1
UY23355A1 UY23355A UY23355A UY23355A1 UY 23355 A1 UY23355 A1 UY 23355A1 UY 23355 A UY23355 A UY 23355A UY 23355 A UY23355 A UY 23355A UY 23355 A1 UY23355 A1 UY 23355A1
Authority
UY
Uruguay
Prior art keywords
active
antihelmintics
formulation
application
anthelmintic
Prior art date
Application number
UY23355A
Other languages
English (en)
Inventor
Hans Dr Roechling
Dieter Dr Duewel
Karlheinrich Dr Schmid
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of UY23355A1 publication Critical patent/UY23355A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedimiento para producir un preparado activo como antihelmítico que como sustancia activa contiene por lo menos un bencimidazol, benzotiazol o probencimidazol (particularmente fenbendazol), activo como antihelmítnico, caracterizado porque la sustancia activa se dispersa en forma finamente dividida en un agente fomentador de la penetración y luego se lleva a una apropiada forma de presentación y administración.
UY23355A 1991-01-19 1992-01-16 Formulacion para verter destinada a la aplicacion de antihelminticos UY23355A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4101540 1991-01-19

Publications (1)

Publication Number Publication Date
UY23355A1 true UY23355A1 (es) 1992-01-23

Family

ID=6423341

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23355A UY23355A1 (es) 1991-01-19 1992-01-16 Formulacion para verter destinada a la aplicacion de antihelminticos

Country Status (15)

Country Link
EP (1) EP0496316A1 (es)
JP (1) JPH04312504A (es)
AU (1) AU658598B2 (es)
BR (1) BR9200163A (es)
CA (1) CA2059602A1 (es)
CS (1) CS14992A3 (es)
FI (1) FI920190A (es)
HU (1) HU208623B (es)
IE (1) IE920150A1 (es)
MX (1) MX9200225A (es)
NO (1) NO920234L (es)
PL (1) PL293227A1 (es)
TR (1) TR27833A (es)
UY (1) UY23355A1 (es)
YU (1) YU2792A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9207344A (es) * 1991-12-16 1993-07-01 Alza Corp Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
FR2755824B1 (fr) * 1996-11-19 1999-01-08 Virbac Sa Formulation galenique des benzimidazoles a usage topique, son procede de preparation et ses utilisations
CR6243A (es) * 1999-09-20 2008-04-16 Syngenta Participations Ag Formulaciones plaguicidas que contienen tensoactivo de poliarilfenolfosfatoester alcoxilado y tensoactivo de lignosulfonato alcoxilado
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
WO2001095723A1 (en) * 2000-06-15 2001-12-20 Ssl International Plc Parasiticidal composition
PT2347654T (pt) 2001-09-17 2019-05-30 Elanco Us Inc Formulação para o controlo de piolhos ou carrapatos em bovinos
US11160867B2 (en) * 2017-05-11 2021-11-02 Auburn University Anti-protozoal compounds and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA751024B (en) * 1974-03-11 1976-01-28 Lilly Co Eli Control of animal parasites with benzimidazoles
US4018932A (en) * 1975-11-03 1977-04-19 American Cyanamid Company Anthelmintic pour-on formulations for topical use on domestic and farm animals
DE3029426A1 (de) * 1980-08-02 1982-03-11 Bayer Ag, 5090 Leverkusen Gegen zwecken wirksame pour-on-formulierungen
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
US4607050A (en) * 1981-10-19 1986-08-19 Wellcome Australia Limited Method of controlling insects and parasites with an aqueous localized pour-on formulation
MA19678A1 (fr) * 1982-01-13 1983-10-01 Ciba Geigy Ag Agents anti-helmintiques.
GB8304927D0 (en) * 1983-02-22 1983-03-23 Wellcome Found Pesticidal formulations
NZ208992A (en) * 1983-08-12 1987-03-06 Ici Australia Ltd Endoparasiticidal compositions for topical administration,containing ether or glycol carboxylate ester
DE3411627A1 (de) * 1984-03-29 1985-10-03 Bayer Ag, 5090 Leverkusen Stabilisierte anthelmintische formulierungen

Also Published As

Publication number Publication date
HU208623B (en) 1993-12-28
HU9200171D0 (en) 1992-05-28
PL293227A1 (en) 1992-11-16
FI920190A0 (fi) 1992-01-16
NO920234D0 (no) 1992-01-17
HUT62453A (en) 1993-05-28
TR27833A (tr) 1995-08-31
BR9200163A (pt) 1992-10-06
YU2792A (sh) 1995-01-31
EP0496316A1 (de) 1992-07-29
FI920190A (fi) 1992-07-20
JPH04312504A (ja) 1992-11-04
NO920234L (no) 1992-07-20
CA2059602A1 (en) 1992-07-20
AU658598B2 (en) 1995-04-27
AU1027792A (en) 1992-08-06
IE920150A1 (en) 1992-07-29
CS14992A3 (en) 1992-11-18
MX9200225A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
ES2060593T3 (es) Sistema de aporte de farmacos.
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
ES2139002T3 (es) Terapia medicamentosa citotoxica.
UY27186A1 (es) Formulación farmacéutica
AR029655A1 (es) Mejoras en formulaciones en pasta
PE19496A1 (es) Formulacion de analogo de insulina humana
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
AR020051A1 (es) Procedimiento de uso y uso de una combinacion de un anticuerpo anti-erbb2 y un agente quimicoterapeutico distinto de un derivado de antraciclina para la manufactura de un medicamento util para el tratamiento de cancer
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
AR059723A2 (es) Composicion de altas dosis de ibandronato
BRPI0519647A2 (pt) métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero
NO874150D0 (no) Preparater inneholdende propylenglykol og/eller polyetylenglykol og urinstoff som aktive hovedkomponenter og anvendelse derav.
ECSP066553A (es) Formas de administración masticables, no comprimidas dosificadas individualmente.
BR0211673A (pt) Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
BR0306501A (pt) Método para uso e produção de um tampão com medicamento
UY23355A1 (es) Formulacion para verter destinada a la aplicacion de antihelminticos
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
YU46705B (sh) Postupak za proizvodnju matrice za ispuštanje i/ili doziranje doziranje lekovite aktivne materije
BR112021017878A2 (pt) Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação
ES2131673T3 (es) Solucion que contiene igf-1.
BR0316770A (pt) Formulação farmacêutica, método de produção da mesma e método de tratamento médico
AR015362A1 (es) Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de acne vulgaris y/o para producir efectos anti-envejecimiento